Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Julphar
Fish and Richardson
Argus Health
UBS
Dow
Express Scripts
Deloitte
Cantor Fitzgerald

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LIVALO

« Back to Dashboard

Clinical Trials for Livalo

Trial ID Title Status Sponsor Phase Summary
NCT00344370 Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia Completed Kowa Research Europe Phase 3 This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.
NCT00846118 Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS) Unknown status Chieko Hamada N/A The purpose of this study is to verify whether pitavastatin prevents from cardiovascular events and improves the mortality in chronic hemodialysis patients with hypercholesteremia.
NCT00889226 Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia Completed JW Pharmaceutical Phase 4 A randomized, open label, dose titration study to evaluate the efficacy and safety of Pitavastatin compared to atorvastatin in Type 2 Diabetes Mellitus with hypercholesterolemia
NCT01057433 Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin Completed Kowa Research Institute, Inc. Phase 4 This is a Phase 4, single center, open label, fixed-sequence, 2-way drug-drug interaction study.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Livalo

Condition Name

Condition Name for Livalo
Intervention Trials
Hyperlipidemia 6
Dyslipidemia 6
Hypertension 3
Obesity 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Livalo
Intervention Trials
Hyperlipidemias 8
Dyslipidemias 7
Diabetes Mellitus 2
Hypercholesterolemia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Livalo

Trials by Country

Trials by Country for Livalo
Location Trials
United States 91
Korea, Republic of 4
Denmark 1
Netherlands 1
Japan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Livalo
Location Trials
Texas 6
New York 5
California 4
North Carolina 4
Florida 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Livalo

Clinical Trial Phase

Clinical Trial Phase for Livalo
Clinical Trial Phase Trials
Phase 4 10
Phase 3 4
Phase 1 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Livalo
Clinical Trial Phase Trials
Completed 10
Unknown status 5
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Livalo

Sponsor Name

Sponsor Name for Livalo
Sponsor Trials
Kowa Research Institute, Inc. 6
JW Pharmaceutical 6
Kowa Pharmaceuticals America, Inc. 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Livalo
Sponsor Trials
Other 29
Industry 17
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Fish and Richardson
Cantor Fitzgerald
Farmers Insurance
Boehringer Ingelheim
Daiichi Sankyo
Cipla
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.